Top1000 Scholar

Scholarly Index

G. Kees Hovingh

Novo Nordisk (Denmark); 28,892 total citations; 305 total publications; best world rank #87

Novo Nordisk (Denmark)

28,892Total citations
305Total publications
73H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Lipoproteins and Cardiovascular HealthLifetime177DK 499.17
Cancer, Lipids, and MetabolismLifetime294DK 598.80
Diabetes, Cardiovascular Risks, and LipoproteinsLifetime375DK 698.67
Lipid metabolism and disordersLifetime181DK 897.82
Atherosclerosis and Cardiovascular DiseasesLifetime750DK 995.67
Pharmaceutical Economics and PolicyLifetime530DK 794.46
Cholesterol and Lipid MetabolismLifetime689DK 694.47
Lipoproteins and Cardiovascular Health2021-202587DK 597.75
Atherosclerosis and Cardiovascular Diseases2021-202593DK 494.35
Diabetes, Cardiovascular Risks, and Lipoproteins2021-2025469DK 1390.64
Adipokines, Inflammation, and Metabolic Diseases2021-2025407DK 885.46
Metabolism, Diabetes, and Cancer2021-2025585DK 3085.60
Lipid metabolism and disorders2021-2025243DK 781.66
Pharmacology and Obesity Treatment2021-2025558DK 2469.95